Laurus Labs is a research-driven CDMO supporting the development and manufacturing of peptides, oligonucleotides and complex conjugates.

We bring together deep scientific expertise in process and analytical development with the industrial capabilities required to translate increasingly sophisticated therapeutics into robust, scalable and commercially viable processes.

From advanced building blocks and early CMC development through drug substance, drug product and commercial supply, our approach starts with a clear understanding of our customers development challenges and program priorities – enabling us to define CMC strategies that balance scientific requirements, manufacturability and long-term supply.

Our commitment to responsible science and manufacturing is underpinned by strong Environmental, social and Governance (ESG) principles, embedding sustainability into the way we develop, scale and manufacture tomorrow’s therapeutics.